L1CAM and colorectal carcinoma: In this context, we propose evaluating L1CAM as another potential biomarker, not directly for CRC detection, but rather as an indicator for the initiation of immune responses, a factor that might play a pivotal role in the broader landscape of colonic inflammation and subsequent oncogenesis.